InvestorsHub Logo
icon url

stoneroad

10/22/13 6:00 AM

#145820 RE: entdoc #145801

ENT, so in your opinion Roche takes out PPHM for essentially 2 bucks and change? Seems a bit absurd and quite in contrast to figures being thrown around by SK. Not to mention quite inferior to the partnership deal on the table last summer.

What makes you come up with such a paltry figure?
icon url

pphmtoolong

10/22/13 10:27 AM

#145865 RE: entdoc #145801

Entdoc, in a David vs Goliath "negotiation" it's pretty clear that David will get schooled by the big guy. However, if it's a David vs Goliath1 vs Goliath2, while the big guys hammer each other, little David may do quite nicely. If Bavi and the anti-PS platform have the goods, I hope at least two Goliaths will come after Peregrine. In that scenario even those financial geniuses in Tustin ought to figure out how to make us a pile of money.

In my view all the rest is noise. We need great news from the lab for the preclinical data and one more jolt of solid news from the clinical trials. We are getting closer on both, but not quite there yet. To get a great deal soon, we need blowout news from both fronts. We'll see.

GLTA, Paul